Showing results (1401-1410 of 1,611) with videos related to

Sort By:
Pageof 162
JAMA Oncology|June 4, 2018
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study, Christina Fitzmaurice, Tomi F Akinyemiju, et al.
JAMA Oncology|June 5, 2018
Everolimus Plus Exemestane vs Everolimus or Capecitabine Monotherapy for Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer: The BOLERO-6 Randomized Clinical TrialGuy Jerusalem, Richard H de Boer, Sara Hurvitz, et al.
JAMA Oncology|June 5, 2018
Association of Exercise With Mortality in Adult Survivors of Childhood CancerJessica M Scott, Nan Li, Qi Liu, et al.
JAMA Oncology|June 23, 2018
Progress and Innovations in the Management of Adult Acute Lymphoblastic LeukemiaElias Jabbour, Ching-Hon Pui, Hagop Kantarjian
JAMA Oncology|August 12, 2018
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical TrialBaohui Han, Kai Li, Qiming Wang, et al.
JAMA Oncology|May 5, 2017
Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome AtlasDezheng Huo, Hai Hu, Suhn K Rhie, et al.
JAMA Oncology|September 10, 2016
Effect of a Patient-Centered Communication Intervention on Oncologist-Patient Communication, Quality of Life, and Health Care Utilization in Advanced Cancer: The VOICE Randomized Clinical TrialRonald M Epstein, Paul R Duberstein, Joshua J Fenton, et al.
JAMA Oncology|May 19, 2017
Targeted Therapy as an Alternative to Whole-Brain Radiotherapy in EGFR-Mutant or ALK-Positive Non-Small-Cell Lung Cancer With Brain MetastasesPablo Martínez, Raymond H Mak, Geoffrey R Oxnard
JAMA Oncology|May 19, 2017
Association Between Combined TMPRSS2:ERG and PCA3 RNA Urinary Testing and Detection of Aggressive Prostate CancerMartin G Sanda, Ziding Feng, David H Howard, et al.
JAMA Oncology|April 28, 2017
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesArvind Dasari, Chan Shen, Daniel Halperin, et al.
Pageof 162